Search for Clinical Trial Results
Fibromatosis, Aggressive - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients Condition: Desmoid-type Fibromatosis Date: 2015-01-28 Interventions: Other: Observational approach Patients will be placed under wait and see approach without any specific t |
Active, not recruiting |
Study Name: Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Condition: Desmoid-Type Fibromatosis Date: 2014-02-17 Interventions:
|
Completed |
Study Name: Study to Evaluate Imatinib in Desmoid Tumors Condition:
|
Completed |
Study Name: Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis Condition: Desmoid Tumor Date: 2006-02-06 Interventions: Drug: imatinib mesylate |
Recruiting |
Study Name: 18F-FES PET/CT in Imaging Patients With Desmoid Tumors Condition:
|
Withdrawn |
Study Name: Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors Condition:
Date: 2009-09-15 Interventions: Drug: Hydroxyurea Patients will take oral hydroxyurea with a starting dose of 20 mg/kg daily. Patients w |
Active, not recruiting |
Study Name: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma Condition:
Date: 2009-06-25 Interventions: Drug: Imatinib Mesylate 800 mg p.o./day (400 mg b.i.d.) for a maximum of 24 months |
Recruiting |
Study Name: Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors Condition:
|
Available |
Study Name: Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies Condition:
Date: 2016-11-02 Interventions: Drug: PF-03084014 Two patients enrolled in this study will continue receiving 80mg BID doses of PF-03084 |
Completed |
Study Name: A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome Condition:
|